What are the major opportunities in the Nuclear Medicine Diagnostics market? What are the strategies for the Nuclear Medicine Diagnostics market?

For detailed insights on the major opportunities and strategies in the Nuclear Medicine Diagnostics market, Read More

How does the Nuclear Medicine Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Nuclear Medicine Diagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Nuclear Medicine Diagnostics market growth? SWOT analysis of the Nuclear Medicine Diagnostics market.

For detailed insights on the key dynamics influencing the Nuclear Medicine Diagnostics market growth and SWOT analysis of the Nuclear Medicine Diagnostics industry, Read More

Nuclear Medicine Diagnostics Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Nuclear Medicine Diagnostics Market Report 2026

Name: Nuclear Medicine Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals), By Application (Cardiology, Thyroid, Neurology, Oncology, Other Applications), By End-User (Hospitals And Diagnostic Centers, Research Institutes) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Nuclear Medicine Diagnostics Market Overview

• Nuclear Medicine Diagnostics market size has reached to $7.88 billion in 2025

• Expected to grow to $13.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%

• Growth Driver: Surge In Cancer Cases Drives Nuclear Medicine Diagnostics Market

• Market Trend: Advancements In Nuclear Medicine Diagnostics Define The Future Of Patient-Centric Solutions

• North America was the largest region in 2025.

What Is Covered Under Nuclear Medicine Diagnostics Market?

Nuclear medicine uses radioactive substances inside the body to diagnose illnesses or to target and remove diseased or damaged organs and tissue (for treatment). Nuclear medicine includes the use of radioactive drugs for research, therapeutic, and diagnostic purposes. Radioactive tracers are used in diagnostic nuclear medicine to visualize and/or measure the overall or local function of an organ.

The main types of nuclear medicine diagnostics are SPECT radiopharmaceuticals and PET radiopharmaceuticals. A single-photon emission computerized tomography (SPECT) Radiopharmaceuticals refer to gamma-ray tomographic imaging methods that are used in nuclear medicine. The various applications involved are cardiology, thyroid, neurology, oncology and others and the end-users include hospitals and diagnostic centers and research institutes.

Nuclear Medicine Diagnostics market report bar graph

What Is The Nuclear Medicine Diagnostics Market Size and Share 2026?

The nuclear medicine diagnostics market size has grown rapidly in recent years. It will grow from $7.88 billion in 2025 to $8.84 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing use of radioactive tracers in diagnostics, expansion of hospital-based nuclear medicine units, rising demand for functional imaging, availability of technetium-based radiopharmaceuticals, growth of clinical research in nuclear medicine.

What Is The Nuclear Medicine Diagnostics Market Growth Forecast?

The nuclear medicine diagnostics market size is expected to see rapid growth in the next few years. It will grow to $13.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to increasing investments in theranostics, rising adoption of precision oncology diagnostics, expansion of PET imaging infrastructure, growing focus on targeted radiopharmaceutical development, increasing regulatory support for nuclear diagnostics. Major trends in the forecast period include increasing adoption of pet-based diagnostic radiopharmaceuticals, rising demand for personalized nuclear diagnostics, growing integration of imaging and therapeutic applications, expansion of oncology-focused nuclear medicine procedures, enhanced focus on short-half-life radiotracers.

Book your 30 minutes free consultation with our research experts

Global Nuclear Medicine Diagnostics Market Segmentation

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:

1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals

2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

What Is The Driver Of The Nuclear Medicine Diagnostics Market?

The increasing prevalence of cancer is expected to propel the growth of the nuclear medicine diagnostics market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body, which can form a mass or lump called a tumor. The rise in prevalence of cancer is due to the aging global population as cancer incidence increases significantly with age and improved healthcare is extending life expectancy. Nuclear medicine diagnostics is used in the detection, staging, and monitoring of various types of cancer, which contain radioactive substances that can be detected by specialized cameras, creating detailed images of the internal structures and functions of organs and tissues. For instance, in May 2025, according to the National Cancer Institute, a US-based intergovernmental organization, in 2022, nearly 20 million people were diagnosed with cancer and 9.7 million died from it, and by 2050 these figures are projected to climb to 33 million new cases and 18.2 million deaths annually. Therefore, the rising cases of cancer are driving the growth of the nuclear medicine diagnostics industry.

Key Players In The Global Nuclear Medicine Diagnostics Market

Major companies operating in the nuclear medicine diagnostics market are Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Theragnostics Ltd., Eczacibasi-Monrol Nuclear Products Co.

Global Nuclear Medicine Diagnostics Market Trends and Insights

Major companies operating in the nuclear medicine diagnostics market are focused on introducing advanced solutions, such as advanced medical technologies, to gain a competitive edge in the market. Advanced medical technologies are cutting-edge technologies in the field of medicine to improve patient outcomes, enhance the standard of care, and promote better health. For instance, in August 2023, Gleneagles Hospital, a Malaysia-based company that provides medical and healthcare services, launched the Nuclear Medicine Unit. The nuclear medicine unit is a specialized facility within a hospital or medical center that is equipped with the latest technology and staffed by highly skilled professionals. This facility is designed to provide early detection, diagnosis, and treatment of diseases using nuclear medicine imaging techniques.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Nuclear Medicine Diagnostics Market?

In March 2025, GE HealthCare Technologies, Inc., a US based medical technology and pharmaceutical company, acquired Nihon Medi Physics Co., Ltd. (NMP), for an undisclosed amount. With this acquisition, GE HealthCare aims to integrate NMP’s deep expertise in radiopharmaceutical development and manufacturing, thereby increasing its capacity to deliver next generation molecular imaging agents in neurology, cardiology, and oncology. Nihon Medi Physics Co., Ltd. is a Japan based radiopharmaceutical company that offers nuclear medicine diagnostics through its development and supply of radioactive pharmaceuticals for diagnostic nuclear medicine procedures.

Regional Outlook

North America was the largest region in the nuclear medicine diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Nuclear Medicine Diagnostics Market?

The nuclear medicine diagnostics market consists of sales of renal scan, bone scan, gallium scan, heart scan, brain scan and breast scan diagnostics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nuclear Medicine Diagnostics Market Report 2026?

The nuclear medicine diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Nuclear Medicine Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$8.84 billion
Revenue Forecast In 2035	$13.77 billion
Growth Rate	CAGR of 12.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Theragnostics Ltd., Eczacibasi-Monrol Nuclear Products Co.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Nuclear Medicine Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Nuclear Medicine Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Nuclear Medicine Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Nuclear Medicine Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Pet-Based Diagnostic Radiopharmaceuticals

4.2.2 Rising Demand For Personalized Nuclear Diagnostics

4.2.3 Growing Integration Of Imaging And Therapeutic Applications

4.2.4 Expansion Of Oncology-Focused Nuclear Medicine Procedures

4.2.5 Enhanced Focus On Short-Half-Life Radiotracers

5. Nuclear Medicine Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Diagnostic Centers

5.2 Nuclear Medicine Clinics

5.3 Research Institutes

5.4 Oncology Centers

5.5 Academic Medical Institutions

6. Nuclear Medicine Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nuclear Medicine Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Nuclear Medicine Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Nuclear Medicine Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Nuclear Medicine Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Nuclear Medicine Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nuclear Medicine Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nuclear Medicine Diagnostics Market Segmentation

9.1. Global Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

9.2. Global Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cardiology, Thyroid, Neurology, Oncology, Other Applications

9.3. Global Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Diagnostic Centers, Research Institutes

9.4. Global Nuclear Medicine Diagnostics Market, Sub-Segmentation Of SPECT Radiopharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals

9.5. Global Nuclear Medicine Diagnostics Market, Sub-Segmentation Of PET Radiopharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

10. Nuclear Medicine Diagnostics Market Regional And Country Analysis

10.1. Global Nuclear Medicine Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Nuclear Medicine Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nuclear Medicine Diagnostics Market

11.1. Asia-Pacific Nuclear Medicine Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nuclear Medicine Diagnostics Market

12.1. China Nuclear Medicine Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nuclear Medicine Diagnostics Market

13.1. India Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nuclear Medicine Diagnostics Market

14.1. Japan Nuclear Medicine Diagnostics Market Overview

14.2. Japan Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nuclear Medicine Diagnostics Market

15.1. Australia Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nuclear Medicine Diagnostics Market

16.1. Indonesia Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nuclear Medicine Diagnostics Market

17.1. South Korea Nuclear Medicine Diagnostics Market Overview

17.2. South Korea Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nuclear Medicine Diagnostics Market

18.1. Taiwan Nuclear Medicine Diagnostics Market Overview

18.2. Taiwan Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nuclear Medicine Diagnostics Market

19.1. South East Asia Nuclear Medicine Diagnostics Market Overview

19.2. South East Asia Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nuclear Medicine Diagnostics Market

20.1. Western Europe Nuclear Medicine Diagnostics Market Overview

20.2. Western Europe Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nuclear Medicine Diagnostics Market

21.1. UK Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nuclear Medicine Diagnostics Market

22.1. Germany Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nuclear Medicine Diagnostics Market

23.1. France Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nuclear Medicine Diagnostics Market

24.1. Italy Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nuclear Medicine Diagnostics Market

25.1. Spain Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nuclear Medicine Diagnostics Market

26.1. Eastern Europe Nuclear Medicine Diagnostics Market Overview

26.2. Eastern Europe Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nuclear Medicine Diagnostics Market

27.1. Russia Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nuclear Medicine Diagnostics Market

28.1. North America Nuclear Medicine Diagnostics Market Overview

28.2. North America Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nuclear Medicine Diagnostics Market

29.1. USA Nuclear Medicine Diagnostics Market Overview

29.2. USA Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nuclear Medicine Diagnostics Market

30.1. Canada Nuclear Medicine Diagnostics Market Overview

30.2. Canada Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nuclear Medicine Diagnostics Market

31.1. South America Nuclear Medicine Diagnostics Market Overview

31.2. South America Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nuclear Medicine Diagnostics Market

32.1. Brazil Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nuclear Medicine Diagnostics Market

33.1. Middle East Nuclear Medicine Diagnostics Market Overview

33.2. Middle East Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nuclear Medicine Diagnostics Market

34.1. Africa Nuclear Medicine Diagnostics Market Overview

34.2. Africa Nuclear Medicine Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nuclear Medicine Diagnostics Market Regulatory and Investment Landscape

36. Nuclear Medicine Diagnostics Market Competitive Landscape And Company Profiles

36.1. Nuclear Medicine Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Nuclear Medicine Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Nuclear Medicine Diagnostics Market Company Profiles

36.3.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Perkin Elmer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Nuclear Medicine Diagnostics Market Other Major And Innovative Companies

Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited

38. Global Nuclear Medicine Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nuclear Medicine Diagnostics Market

40. Nuclear Medicine Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Nuclear Medicine Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Nuclear Medicine Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Nuclear Medicine Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Nuclear Medicine Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Nuclear Medicine Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Nuclear Medicine Diagnostics Market, Supply Chain Analysis

Table 4: Global Nuclear Medicine Diagnostics Market, Major Raw Material Providers

Table 5: Global Nuclear Medicine Diagnostics Market, Major Resource Providers

Table 6: Global Nuclear Medicine Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Nuclear Medicine Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Nuclear Medicine Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Nuclear Medicine Diagnostics Market, Major Trends

Table 10: Global Nuclear Medicine Diagnostics Market, Major End Users

Table 11: Global Nuclear Medicine Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Nuclear Medicine Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Nuclear Medicine Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Nuclear Medicine Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Nuclear Medicine Diagnostics Market, Sub-Segmentation Of SPECT Radiopharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Nuclear Medicine Diagnostics Market, Sub-Segmentation Of PET Radiopharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Nuclear Medicine Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Nuclear Medicine Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Nuclear Medicine Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Nuclear Medicine Diagnostics Market - Company Scoring Matrix

Table 96: Siemens AG Financial Performance

Table 97: Bayer Aktiengesellschaft Financial Performance

Table 98: Novartis AG Financial Performance

Table 99: GE Healthcare Technologies Inc. Financial Performance

Table 100: Perkin Elmer Inc. Financial Performance

Table 101: Global Nuclear Medicine Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Nuclear Medicine Diagnostics Market, Competitive Dashboard

Table 103: Global Nuclear Medicine Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Nuclear Medicine Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 105: Global, Nuclear Medicine Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 106: Global, Nuclear Medicine Diagnostics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Nuclear Medicine Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Nuclear Medicine Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Nuclear Medicine Diagnostics Market, Supply Chain Analysis

Figure 4: Global Nuclear Medicine Diagnostics Market, Major Raw Material Providers

Figure 5: Global Nuclear Medicine Diagnostics Market, Major Resource Providers

Figure 6: Global Nuclear Medicine Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Nuclear Medicine Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Nuclear Medicine Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Nuclear Medicine Diagnostics Market, Major Trends

Figure 10: Global Nuclear Medicine Diagnostics Market, Major End Users

Figure 11: Global Nuclear Medicine Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Nuclear Medicine Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Nuclear Medicine Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Nuclear Medicine Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Nuclear Medicine Diagnostics Market, Sub-Segmentation Of SPECT Radiopharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Nuclear Medicine Diagnostics Market, Sub-Segmentation Of PET Radiopharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Nuclear Medicine Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Nuclear Medicine Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Nuclear Medicine Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Nuclear Medicine Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Nuclear Medicine Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Nuclear Medicine Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Nuclear Medicine Diagnostics Market - Company Scoring Matrix

Figure 96: Siemens AG Financial Performance

Figure 97: Bayer Aktiengesellschaft Financial Performance

Figure 98: Novartis AG Financial Performance

Figure 99: GE Healthcare Technologies Inc. Financial Performance

Figure 100: Perkin Elmer Inc. Financial Performance

Figure 101: Global Nuclear Medicine Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Nuclear Medicine Diagnostics Market, Competitive Dashboard

Figure 103: Global Nuclear Medicine Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Nuclear Medicine Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 105: Global, Nuclear Medicine Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 106: Global, Nuclear Medicine Diagnostics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Industry Trends Show Oral Sleep Apnea Devices Market Set to Expand at 12.3% CAGR Until 2029

Strategic Report on Oral Syringes Market: Growth Opportunities and Emerging Challenges

Outlook for Orthopedic Market: Key Developments and Future Strategies to 2029

Future Projections: Oxygen Source Equipment Market to Reach $5.87 Billion by 2029 at 10.3% CAGR

The global medical gloves market report offers strategic insights and market intelligence through 2025.

Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

Equipment Finance Service Market Report 2026 - Global Outlook – By Type (Equipment Loan, Equipment Lease, Other Types), By Provider (Banks, Non-Banking Financial Company (NBFC), Other Providers), By Application (Transpor...

Urology Medical Lasers Market Report 2026 - Global Outlook – By Laser Type (Holmium Laser System, Diode Laser System, Thulium Laser System, Other Laser Types), By Application (Benign Prostatic Hyperplasia (BPH), Urolithi...

Nuclear Imaging Devices And Equipment Market Report 2026 - Global Outlook – By Product Type (SPECT Systems, PET Systems, Planar Scintigraphy Systems), By Application (Oncology, Cardiology, Neurology, Other Applications),...

Refrigerated Display Cases Market Report 2026 - Global Outlook – By Type ( Plug-In, Semi Plug-In, Remote), By Design ( Vertical, Horizontal, Hybrid), By Application ( Retail Stores, Restaurants And Hotels, Other Applicat...

Avionics Market Report 2026 - Global Outlook – By Platform (Commercial Aviation, Military Aviation, Business Jets, General Aviation, Helicopters ), By Sub System (Flight Management and Control, Health Monitoring, Electri...

Note Sorter Market Report 2026 - Global Outlook – By Sorter Type (Small-Sized Note Sorter, Medium-Sized Note Sorter, Large-Sized Note Sorter), By Enterprise Size (Large Enterprises, Small And Medium Enterprises ), By End...

3D Display Market Report 2026 - Global Outlook – By Product ( Volumetric, Stereoscopic), By Technology ( Digital Light Processing, Organic Light-Emitting Diode), By Access Methods ( Conventional or Screen-based Display, ...

Frequently Asked Questions

How big is the Nuclear Medicine Diagnostics Market?

The Nuclear Medicine Diagnostics market was valued at $7.88 billion in 2025, increased to $8.84 billion in 2026, and is projected to reach $13.77 billion by 2030.

What is the Nuclear Medicine Diagnostics market growth?

The global Nuclear Medicine Diagnostics market is expected to grow at a CAGR of 11.7% from 2026 to 2035 to reach $13.77 billion by 2035.

Who are the key players in Nuclear Medicine Diagnostics market?

Some Key Players in the Nuclear Medicine Diagnostics market Include, Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc.,

Major trend in this market includes: Advancements In Nuclear Medicine Diagnostics Define The Future Of Patient-Centric Solutions. For further insights on this market. request a sample here

North America was the largest region in the nuclear medicine diagnostics market in 2025. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South A

Book your 30 minutes free consultation with our research experts

Contact Us